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ABSTRACT  
Introduction: Antibiotic resistance is a major emerging world-wide problem in the intensive care unit (ICU). The aim of this study was 
to study the antimicrobial resistance pattern of microbial isolates from patients in intensive care units (ICUs). Material and methods: All 
isolates from different clinical samples were collected and processed by standard microbiological techniques. Antimicrobial susceptibility 
testing was performed by modified Kirby Bauer method. All gram negative organisms were further tested for ESBL and MBL production. 
Results: Of 451 isolates, 353 (78.2%) were gram negative and 98 (21.7%) were gram positive cocci. The most frequent infections were 
lower respiratory tract infections (32.9%). The most frequently isolated organisms were P. aeruginosa (20.1%) and Staphylococcus 
epidermidis (8.6%). Higher resistance (60-100%) was observed to amoxycillin, ceftazidime, amoxyclav, ciprofloxacin and cotrimoxazole. 
ESBLs production was found in (45.3%) isolates. 75.0% of Staphylococcus aureus and 20.5% of S. epidermidis were MRSA positive. 
85.7% showed MBL production. Conclusion: Surveillance of antibiotic susceptibility patterns of predominant bacteria is necessary to 
monitor changes in susceptibility patterns and to guide the clinician in choosing empirical or directed therapy appropriately, especially in 
ICU setting. 
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INTRODUCTION 
ICUs accommodate the most seriously ill patients in a relatively 
confined environment.[1] Antibiotic resistance is a major 
emerging world-wide problem in the intensive care unit (ICU) 
including India. The patient in the ICU has a 5 to7 fold higher 
risk of nosocomial infection compared with the other patients. 
This is a consequence of impaired defence mechanism, applying 
invasive methods and monitoring devices, exposure to broad-
spectrum antibiotics and the colonization of resistant 
microorganisms. The frequent use of broad-spectrum antibiotics 
results in colonization with resistant Gram-negative bacteria and 
consequently in serious infections.[2-4] Antimicrobial resistance 
has emerged as an important determinant of outcome for 
patients in the ICU.[5] The widespread use of antibiotics put 
tremendous selective pressure on bacteria which develop new 
mechanisms to escape the lethal action of the antibiotics. These 
infections are difficult to treat because of emergence of newer 
β-lactamases such as extended spectrum β-lactamases (ESBL), 
AmpC β-lactamases and Carbapenemases.[6] 
Increased duration of stay, increased number of indwelling 
devices and prolonged or inappropriate use of antibiotics in the 
ICU-leading to selection of multi-resistant ‘super-bugs’- among 
these the methicillin resistant Staphylococcus aureus (MRSA), 
vancomycin-resistant Enterococcus (VRE), extended-spectrum 
β-lactamase-producing GNB, P. aeruginosa, Acinetobacter, 
Glycopeptide intermediate Staphylococcus aureus (GISA), 
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Glycopeptide resistant Staphylococcus aureus (GRSA), 
Stenotrophomonas maltophila and Candida are notable which 
all are associated with significantly increased morbidity and 
mortality.[1,7-8] Continuous spreading of antimicrobial resistance 
is common in ICU that may lead to be a clinical disaster. If this 
resistance spreads, monitoring the use of antimicrobials and 
review of sensitivity patterns are imperative. Study of 
antimicrobial sensitivity patterns in ICUs and critical care units 
(CCUs) are crucial and far more important for giving effective 
treatment and control in the spread of resistance. The present 
study was therefore, designed to study the antimicrobial 
resistance pattern of microbial isolates from patients in intensive 
care units (ICUs) of a tertiary care hospital.  
MATERIALS AND METHODS 
The present prospective study was conducted in the 
Microbiology Department of a teaching tertiary care hospital 
during July 2012-June 2014 and the study was approved by the 
Intuitional Ethics committee. All isolates obtained from 
different clinical samples (e.g. Urine, Pus, Blood, Sputum, BAL, 
Tracheal secretions, CSF, Peritoneal and Pleural fluid) were 
identified based on their characteristic appearance on the media 
and the patterns of biochemical reactions using conventional 
bacteriological methods[9] and evaluated for antibiotic 
susceptibility by the Kirby–Bauer disc diffusion method on 
Muller–Hinton agar (Himedia) according to Clinical and 
Laboratory Standards Institute guidelines (CLSI, 2013).[10] The 
susceptibility of the isolated bacteria were tested against 
ampicillin (10 μg), piperacillin (100 μg), ceftriaxone (30μg) 
ceftazidime (30 μg), cefepime (30 μg), cefotaxime (30 μg), 
gentamicin (30 μg), amikacin (30 μg), ciprofloxacin (30 μg), 
trimethoprim/sulfomethoxazole (1.25/1.23 μg), piperacillin-
tazobactam (100/10 μg), imipenem (10 μg) and nitrofurantoin 
(100 μg). 
The Gram-negative isolates (including members of the family 
Enterobacteriaceae, Pseudomonas aeruginosa and 
Acinetobacter spp.) were subjected to test phenotypically for 
ESBL and MBL production. Quality control was assured by 
concurrent testing with the American Type Culture Collection 
(ATCC) strains including E. coli ATCC 25921, P. aeruginosa 
ATCC 27852 and Staphylococcus aureus ATCC 25923. 
Detection of ESBL: The Gram-negative isolates showing 
resistance (or decreased zone diameter according to the ESBL 
screening method of the Clinical and Laboratory Standards 
Institute) to third generation cephalosporins (i.e. ceftazidime, 
ceftriaxone, cefotaxime, aztreonam, cefpodoxime) were tested 
for ESBL production by using the phenotypic disc confirmatory 
test (PDCT). 
The phenotypic disc confirmatory test (PDCT): This test was 
performed as a disc diffusion test, as recommended by the CLSI. 
The test inoculum (0.5 McFarland’s turbidity) was spread onto 
the MHA by using a sterile cotton swab. (a) Ceftazidime (CA) 
disc (30 μg) and ceftazidime- clavulanic acid (CAC) disc 
containing 20+10 μg of the antibiotics were placed at a distance 
of 30 mm from each other and (b) cefotaxime (CE) disc (30 μg) 
and cefotaxime-clavulanic acid (CEC) disc (20+10 μg) were 
placed at a distance of 30 mm from each other.[10] 
Detection of Metallo – β - Lactamase (MBL): The imipenem 
resistant isolates were tested by the imipenem-EDTA double 
disk synergy test (DDST) as described by Lee et al. The test 
organism was inoculated onto MHA plates as recommended by 
CLSI. An imipenem 10 μg disc was placed 10mm edge to edge 
from a blank disc which contained 10 μl of EDTA (750 μg), 
with overnight incubation at 37°C. An enhancement in the zone 
of inhibition in the area between the imipenem and the EDTA 
discs in comparison with the zone of inhibition on the far side 
of the disc was interpreted as a positive result.[10-11] 
Detection of MRSA: The detection of MRSA done by cefoxitin 
(30 µg) disc diffusion tests. Mueller-Hinton agar (MHA) plates 
were overlaid with a saline suspension with the isolate (turbidity 
matching 0.5McFarland standard) and cefoxitin (30 µg) discs 
were placed after 10 minutes (HiMedia, India). After 24 hours 
incubation at 35ºC, the plates were read using the CLSI cut-off 
points as reference: ≤19 mm for cefoxitin considered as MRSA. 
S. aureus ATCC 25923 (mecA negative) and ATCC 43300 
(mecA positive) were used as controls for all the tests.[12] 
Detection of vancomycin resistance: Minimum inhibitory 
concentration (MIC) for vancomycin for VRE was determined 
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by E-test as per the procedure of CLSI.[4] An isolate is 
considered susceptible to vancomycin if the MIC is ≤ 4µg/ml 
and resistant if MIC ≥ 32 µg/ml.[4] Quality control was assured 
by concurrent testing with the American Type Culture 
Collection (ATCC) strains including two strains of 
Enterococcus faecalis ATCC 29212 and ATCC 51299 were 
used as sensitive and resistant controls, respectively. The MIC 
values of vancomycin for the control strains must be within the 
ranges provided by the CLSI prior proceeding to test 
organisms.[10] 
RESULTS 
During July 2012 to June 2014, 425(46.4%) of the 915 
specimens were culture positive and 490 (53.5%) were culture 
negative. 451 isolates were isolated from 425 culture positive 
specimens. 26 (2.84%) specimen were positive for two different 
bacteria. Out of these, 17 specimens from LRTIs, 7 specimens 
from wound infection and 2 from UTI were positive for two 
different types of bacteria. Out of 451 isolates, 353 (78.2%) 
were gram negative organisms and 98 (21.7%) were gram 
positive cocci. Of these 451 isolates, 157 (34.8%) were isolated 
from respiratory specimens, 128 (28.3%) were from urine, 107 
(23.7%) isolates were from pus, 43 (9.53%) from blood and 16 
(3.54%) isolates were from miscellaneous sample (Table 1). The 
isolation patterns of organisms as well as infection pattern are 
given in Table 1. 
Table 1. Isolates from different clinical sample in ICU Patient
ISOLATES LRTI WOUND UTI SEPTICEMIA MENINGITIS PERITONITIS 
P. aeruginosa 41 31 11 6 1 1 
E. coli 19 19 34 6 3 2 
Klebsiella spp. 32 12 28 3 1 - 
Acinetobacter spp 30 9 14 6 - - 
Citrobacter spp 2 2 14 2 1 - 
Enterobacter spp 2 1 2 1 - - 
Serratia spp 2 1 1 1 - - 
S. maltophila 1 1 1 - - - 
Proteus vulgaris - 1 5 - - - 
Proteus mirabilis - 1 1 1 - - 
CONS 9 11 9 9 - 1 
S. aureus 17 12 2 4 1 - 
Enterococcus 2 6 6 4 3 2 
Total (451) 157 107 128 43 10 6 
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The most frequent infections were lower respiratory tract 
infections 140 (32.9%), urinary tract infection 126 (29.6%) and 
wound infections 100 (23.5%). The most frequently isolated 
organisms among gram negative were 91 P. aeruginosa 
(20.1%), followed by 83 E. coli (18.4), 76 K. pneumoniae 
(16.8%) and 59 Acinetobacter spp (13.0%). Among the gram 
positive, 39 Staphylococcus epidermidis (8.6%), 36 
Staphylococcus aureus (7.9%) and 23 Enterococci spp. (5.1%) 
were frequently isolated. Most frequently isolated bacteria from 
LRTI among gram negative were P. aeruginosa, Acinetobacter 
spp., K. pneumoniae and among gram positive were 
Staphylococcus aureus. 
Very high rate of resistance (60-100%) was observed among P. 
aeruginosa, E.coli, K. pneumoniae, Acinetobacter spp. and 
Staphylococcus aureus isolates to amoxycillin, ceftazidime, 
amoxyclav, ciprofloxacin and cotrimoxazole. Higher resistance 
to macrolides was found for S .aureus than for S. epidermidis. 
Colistin, imipenem and amikacin were the most effective in 
vitro drugs against gram negative isolates and linozolid and 
vancomycin were the most effective against gram positive 
isolates (Table 2). High rate of resistance (60-80%) to third 
generation cephalosporins was observed among isolates of 
Pseudomonas aeruginosa, E. coli and K. pneumoniae.  
Table 2.  Antibiotic Resistant Pattern of Common Isolates in ICU Patient 
AMP –Ampicillin, PC – Piperacillin, G – Gentamicin, AK – Amikacin, CF – Ciprofloxacin,  CAZ – Ceftazidime, CTR – Ceftriaxone, CS 
- Colistin, I – Imipenem, PTZ – Piperacillin-Tazobactum, AMC – Amoxycillin-Clavulinic acid, CAC – Ceftazidime-clavulinic acid, CFS 
– Cefoperazone-sulbactum ,COT - Cotrimoxazole, VA – Vancomycin, CN – Cefoxitin, LZ – Linezolid, E – Erythromycin, NF - 
Nitrofurantoin 
Antibiotics        P. 
aeruginosa 
E .coli Klebsiella Acinetobacter Citrobacter S. aureus Enterococci S. epidermidis 
AMP 91(100) 80(96.3) 76(100) 59(100) 19 (90.4) 34 (94.4) 21(91.3) 21(53.8) 
PC 80(87.9) 65(78.3) 63(82.8) 54(91.5) 14(66.6) 26(72.2) 14(60.8) 19(48.7) 
G 39(42.8) 32(38.5) 33(43.4) 37(62.7) 08(38.0) 11(30.5) 13(56.5) 14(35.8) 
AK 21(23.0) 16(19.2) 17(22.3) 22(37.2) 5(23.8) 08(22.2) 09(39.1) 12(30.7) 
CF 53(58.2) 52(62.6) 60(78.9) 48 (81.3) 8(38.0) 22(61.1) 11(47.8) 13(33.3) 
CAZ 79(86.8) 66(79.5) 65(85.5) 51(84.4) 12(57.1) 22(61.1) -- 16(41.0) 
CTR 79(86.8) 63(75.9) 65(85.5) 51(84.4) 12(57.1) 21(58.3) -- 16(41.0) 
CS 78(85.7) 62(74.6) 65(85.5) 51(84.4) 12(57.1) 20(55.5) -- 15(38.4) 
I 22(24.1) 13(15.6) 14(18.4) 20(33.9) 1(4.7) -- -- -- 
PTZ 30(32.9) 33(39.7) 25(32.8) 33(55.9) 5(23.8) 07(19.4) 11(47.8) 12(30.7) 
AMC 91(100) 62(74.6) 59(77.6) 57(96.6) 7(66.6) 21(58.3) 11(47.8) 15(38.4) 
CAC 40(43.9) 33(39.7) 25(32.8) 27(45.7) 6(28.5) 17(47.2) -- 14(35.8) 
CFS 40(43.9) 33(39.7) 25(32.8) 26(44.0) 6(28.5) 15(41.6) -- 14(35.8) 
COT 91(90.6) 64(79.7) 76(100) 59(100) 17(80.9) 22(61.1) -- 08(20.5) 
VA -- -- -- -- -- 3(8.3) 02(8.6) 00 (00) 
CN -- -- -- -- -- 28(77.7) -- 16(41.0) 
LZ -- -- -- -- -- 00(00) 00(00) 00(00) 
E -- -- --  -- 05(13.8) 04(17.3) 17(43.5) 
NF 5(100) 13(16.4) 9(11.8) 8(38.0) 1(5.0) 00 02(8.6) 02(22.2) 
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Very high rate of resistance (60-100%) was observed among P. 
aeruginosa, E.coli, K. pneumoniae, Acinetobacter spp. and 
Staphylococcus aureus isolates to amoxycillin, ceftazidime, 
amoxyclav, ciprofloxacin and cotrimoxazole. Higher resistance 
to macrolides was found for S .aureus than for S. epidermidis. 
Colistin, imipenem and amikacin were the most effective in 
vitro drugs against gram negative isolates and linezolid and 
vancomycin were the most effective against gram positive 
isolates (Table 2). High rate of resistance (60-80%) to third 
generation cephalosporins was observed among isolates of 
Pseudomonas aeruginosa, E. coli and K. pneumoniae.  
Among gram negative isolates, production of ESBLs were 
found in 160 (45.3 %) of frequently isolated organism. The 
ESBLs producing strains were, 39 P. aeruginosa (42.8%), 44 E. 
coli (53%),43 K. pneumoniae (56.5%), 23 Acinetobacter spp 
(38.9%) and 6 (28.5%) Citrobacter spp (Figure 1). However, in 
this study only 39 (24.37%) of ESBLs producing isolates were 
susceptible to tazobactum. In this study, high sensitivity to 
Colistin (100%), Polymyxin B (100%) and Imipenem (85-90%) 
was seen among ESBLs producing bacteria while only 30-35% 
Amikacin sensitivity was seen among ESBLs producing 
bacteria.  
 
Figure 2. Distribution of ESBLs producing strains 
Among the Staphylococcus spp 75.0% (27/36) of 
Staphylococcus aureus and 20.5% (8/39) of S. epidermidis were 
MRSA positive.13.88% (5) of Staphylococcus aureus and 13.1 
% (3) of Enterococci spp. were vancomycin resistant. There was 
no resistance against linozolid. 
Among the 353 gram negative isolates, 70 (19.8%) showed 
imipenem resistance by the disc diffusion method. Of these, 42 
(60.0 %) were non-fermenters and 28 (40.0%) were 
Enterobacteriaceae. Among Imipenem resistant non fermenter 
isolates 36 (85.7%) showed MBL production by the imipenem 
(IMP)-EDTA combined disc test, which include 20 (55.5%) 
Pseudomonas aeruginosa and 16 (44.4%) Acinetobacter spp. 
Among Imipenem resistant Enterobacteriaceae, 22 (78.5%) 
were positive for MBL which include 10 (45.4%) E. coli, 11 
(50%) Klebsiella pneumoniae and 1 (4.5%) Citrobacter spp. 
DISCUSSION 
The emergence of antimicrobial resistance in ICUs is of great 
concern as it increases the likelihood of drug interactions/side 
effects and cost of therapy due to use of newer antibiotics. 
Resistance may also be responsible for prolonged hospital stays 
and can affect prognosis. The problem of resistance in a hospital 
is difficult to understand without the knowledge of antimicrobial 
use pattern[8,12,13] so monitoring the use of antimicrobial and 
review of sensitivity pattern are important. 
Organisms were isolated in 46.4 % out of cultures investigated, 
compared to 36.8% by Sheth et al and 64.7 % in Indonesian ICU 
study.[13] The most common infections in our study were LRTI, 
urinary tract infection and wound infections which are similar to 
other Indian studies.[2,3,11.12] 
This result revealed that P. aeruginosa, Klebsiella spp., E. coli, 
Acinetobacter spp and Staphylococcus aureus were most 
predominant isolates in ICU of KIMS, Narketpally, Nalgonda. 
In Asian countries including India, the most frequent pathogen 
isolated from infections in the ICU are P. aeruginosa, Klebsiella  
spp., E. coli, Enterococcus and Staphylococcus aureus.[12,16] In 
Thailand the predominance causative pathogens in ICU, were 
the imipenem resistant P .aeruginosa, ceftazidime-resistant 
Acinetobacter baumannii, third-generation-cephalosporin-
resistant K. pneumoniae, and quinolone-resistant E. coli.[17] 
Another study performed at ICU of a tertiary care centre in 
Saudi Arabia showed that the most frequent pathogens are 
Acinetobacter baumannii, P. aeruginosa, E. coli, K. 
pneumonia.[18] Recently, similar studies were conducted in 
hospitals and several ICUs in Asian countries including 
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Singapore[28] and Nepal,[29] demonstrated that the most frequent 
microorganism derived from ICU samples were P. aeruginosa, 
Klebsiella spp. and Staphylococcus. For example, in 12 ICUs in 
seven Indian cities, overall 87.5% of all Staphylococcus aureus 
health care associated infections were caused by methicillin-
resistant strains, 71.4% of Enterobacteriaceae were resistant to 
ceftriaxone and 26.1% to piperacillin-tazobactam, 28.6% of the 
P. aeruginosa strains were resistant to ciprofloxacin, 64.9% to 
ceftazidime and and 42.0% to imipenem.[2,16]  
High rate of resistance (60-80%) to third generation 
cephalosporins was observed among isolates of Pseudomonas 
aeruginosa, E. coli and K. pneumoniae. Production of ESBLs 
was found in 30-40% of frequently isolated organism. The 
ESBLs rate of P. aeruginosa, E.coli, K. pneumonia, 
Acinetobacter spp. and Citrobacter spp. were 43%, 53%, 56%, 
47% and 30% respectively. Third generation cephalosporin such 
as ceftazidime were extensively used in our hospital before 
therefore, the resistance observed here may be due to ESBLs, 
which may appear under the selective influence of the extensive 
use of antibiotics. 
Tazobactum is expected to inhibit ESBLs. Piperacillin-
tazobactum should be good choice for inhibiting ESBL 
producing microorganisms. However, in this study only 26.6% 
of ESBLs producing isolates were susceptible to tazobactum. 
This is probably a result of the widespread distribution of non 
TEM/SHV ESBLs, such as PER-I which is resistant to 
tazobactum. 
In this study, Colistin (100%), Polymyxin B (100%) and 
Imipenem (85-90%) was highly sensitive for ESBLs producing 
bacteria while Amikacin was sensitive for 30-35% of ESBLs 
producing bacteria. 
In this study 77.1% of Staphylococcus aureus and 41.0 % of S. 
epidermidis were MRSA positive. 8.3% of Staphylococcus 
aureus and 8.6 % of Enterococci spp. were vancomycin 
resistant. The association between intensity of care and risk for 
MRSA acquisition is well described. ICUs with more ‘at‐risk’ 
patient populations are more prone to higher rates of MRSA 
acquisition for a number of reasons including more staff to 
patient contact, higher use of medical devices compared to units 
with less acute patients and more selective pressures induced by 
antibiotic therapy.[23]  There was no resistance against linozolid. 
This may be due to limited use of linozolid against these 
bacteria. 
Lower respiratory tract infections (LRTI) are the most common 
bacterial infections among patients in intensive care units 
(ICUs) occurring in 10-25% of all ICU patients and resulting in 
high overall mortality, which may range from 22-71%.[1,2] Most 
common bacterial agents of LRTI in the ICU are 
Pseudomonas, Acinetobacter, Klebsiella, Citrobacter, Escheric
hia coli.[3-5] The commonly isolated organisms in this study 
among gram negative were P. aeruginosa E.coli. K. 
pneumoniae, Acinetobacter spp. and among gram positive were 
Staphylococcus aureus 36(8.90%), Staphylococcus epidermidis 
39 (7.88%) and Enterococci spp. which are similar to other 
studies.[2,3,28] 
CONCLUSION 
Antimicrobial resistance has emerged as an important 
determinant of outcome for patients in the ICU. The escalating 
problem of antimicrobial resistance has substantially increased 
overall health care cost. This increase is a result of prolonged 
hospitalization and convalescence associated with antibiotic 
treatment failures. The need to develop new antimicrobial 
agents and the implementation of broader infection control and 
public health interventions aimed at curbing the spread of 
antibiotic resistance pathogens. ICUs are unique because they 
have seriously ill patients in confined environment where 
antibiotic use is extremely common. Effective strategies for the 
prevention of antimicrobial resistance in ICUs have focused on 
limiting the unnecessary use of antibiotics and strict 
implementation of infection control practices. Clinicians 
treating critically ill patients should consider antimicrobial 
resistance as an important part of their routine treatment plans. 
Careful, focused attention to this problem at the local ICU level, 
using a multidisciplinary intervention, will have the greatest 
likelihood of limiting the development and dissemination of 
antibiotic-resistant infections. The prescribing of antibiotics in 
the ICU is usually empiric. Therefore, the ongoing surveillance 
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of antibiotic susceptibility patterns of predominant bacteria is a 
fundamental effort to monitor changes in susceptibility patterns 
and to guide the clinician in choosing empirical or directed 
therapy appropriately, especially in ICU setting. Appropriate 
antibiotic utilization in ICU is crucial not only in ensuring an 
optimal outcome, but also in preventing the emergence of multi 
drug resistance bacteria. 
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